TABLE 3. Comparison between Fibroscan® and ARFI® liver stiffness of ethanol (OH) and HCV etiology among groups with and without HCC and MELD score analysis.

Parameters/Groups	HCC HCV (n=21)	Non-HCC HCV (n=9)	p
Fibroscan®) (kPa) MELD	30.89±4.09 14.28±6.60	22.1±4.04 11.63±4.41	0.353 0.312
ARFI®) (m/s)	2.14±0.12	2.06±0.09	0.979
Parameters/Groups	OH (n=1) HCC	OH (n=18) non-HCC	p
Fibroscan®) (kPa) MELD	26.6±NA 21	44.88±5.62 12.18±(5.0)	0.647 NA
ARFI®) (m/s)	2.31±0.43	2.21±0.11	0,81
Parameters/Groups	Non-HCC HCV (n=9)	Non-HCC OH (n=18)	p
Fibroscan®) (kPa) MELD	22.1±4.04 11.63±4.41	44.88±5.62 12.18±(5.0)	0.022 0.48
ARFI®) (m/s)	2.06±0.09	2.21± 0.11	0.961

Mean and standard deviation; MELD=Model for End Stage Liver Disease; HCC=hepatocellular carcinoma; NA=not applicable